New kallikrein 7 inhibitors

• 收藏
• 分享

专利权人:

Sixera Pharma AB

发明人:

Linschoten, Marcel

申请号：

AU20150209759

公开号：

AU2015209759(B2)

申请日:

2015.01.22

申请国别(地区):

澳大利亚

年份:

2018

代理人:

摘要：

The present invention relates to methods for inhibiting the activity of human kallikrein 7 (KLK7) (also known as serine protease stratum corneum chymotryptic enzyme, SCCE). The invention further relates to the use of KLK7 inhibitors of Formula I for the treatment and prevention of diseases, more specifically for the treatment and prevention of skin diseases. The invention also provides new compounds demonstrated to be inhibitors of KLK7.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/